Business Wire
-
Agilent Launches New Advanced Dilution System To Increase Lab Efficiency
4/1/2024
Agilent Technologies Inc. today announced the launch of the Advanced Dilution System, the ADS 2, a new automation workflow solution that will increase productivity, lower cost of ownership, and improve the overall efficiency within the laboratory.
-
Grace Health Technology Launches New Laboratory Management Software
3/29/2024
Grace Health Technology, a leading provider of innovative software solutions for the healthcare industry, today announced the expansion of its laboratory-specific applications with the launch of a groundbreaking new application poised to revolutionize laboratory technology and enhance efficiency in healthcare settings.
-
Bostongene Recognized As Designated Laboratory For The ComboMATCH Precision Medicine Clinical Trial
3/26/2024
BostonGene, a leading provider of AI-driven, molecular and immune profiling solutions, today announced its participation in the Molecular Analysis for Combination Therapy Choice (ComboMATCH) precision medicine initiative as a designated laboratory.
-
STEMCELL Technologies Announces FDA De Novo Classification For Its EasySep CD138 Positive Selection Kit To Support Cancer Diagnostic Tests
3/26/2024
STEMCELL Technologies is pleased to announce that its new EasySep Human Bone Marrow CD138 Positive Selection Kit has been granted de novo classification by the U.S. Food and Drug Administration (FDA) as a first-of-its-kind in vitro diagnostic (IVD) medical device for hematopoietic cell enrichment.
-
Nucleus Genomics Launches To Bring Whole-Genome Sequencing To The Public
3/25/2024
Nucleus Genomics, the next-generation genetic testing and analysis company, today announced the launch of its DNA analysis product to bring the benefits of personalized medicine to everyone.
-
CMS Designates The NavDx Test As An Advanced Diagnostic Laboratory Test (ADLT)
3/21/2024
Naveris, Inc., the leader in precision oncology diagnostics for viral-related cancers, today announced that the Centers for Medicare & Medicaid Services (CMS) has designated NavDx, the Tumor Tissue Modified Viral (TTMV)-HPV DNA blood test that aids in the detection of HPV-driven cancer, as an Advanced Diagnostic Laboratory Test (ADLT).
-
Babson Diagnostics To Launch Transformative Blood Testing Service With Leading Retail Partners
3/21/2024
Babson Diagnostics, a science-first health technology company, announced today that it will launch BetterWay blood testing with three retail partners in Austin and San Antonio.
-
Spectrum Solutions Releases The New SimplyPERIO Saliva Test Powered By SimplyTest
3/21/2024
Spectrum Solutions, saliva diagnostic biotech leader, today announced the official release of a new saliva diagnostic testing innovation, SimplyPERIO.
-
Genseq Selects Sapio LIMS To Power Best-In-Class Next-Generation Sequencing Services
3/18/2024
Genseq, a Dublin-based, CAP-accredited laboratory providing a range of services for biopharma and clinical research, has adopted the science-aware lab informatics platform from Sapio Sciences to manage its next-generation sequencing (NGS) and biobanking workflows.
-
Revvity Introduces New Workflow To Accelerate Newborn Sequencing Research
3/15/2024
Revvity, Inc. today announced the introduction of a flexible end-to-end workflow solution for newborn research, enabling users to utilize different instruments, reagents and databases based on a lab’s needs.